An Open Label, Safety, Tolerability, and Steady State Pharmacokinetic Drug Interaction Study of the Effect of Co-administered Quetia[pine Fumarate (Seroquel ) and Divalproex Sodium (Depakote Sprinkle) in Subjects with Schizophrenic/Schizoaffective Disorders or in Subjects with Bipolar Disorder

Study identifier:5077IL/0120

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Open Label, Safety, Tolerability, and Steady State Pharmacokinetic Drug Interaction Study of the Effect of Co-administered Quetia[pine Fumarate (Seroquel ) and Divalproex Sodium (Depakote Sprinkle) in Subjects with Schizophrenic/Schizoaffective Disorders or in Subjects with Bipolar Disorder

Medical condition

mania

Phase

Phase 1

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

-

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria